Corton Capital’s Phibro Animal Health PAHC Stock Holding History

Corton Capital’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-14,182	Closed	-$362K	–	352
2025 Q2	$362K	Buy	+14,182	New	+$309K	0.42%	44

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Corton Capital's PAHC Position: Q3 2025 in Review

Corton Capital sold out of Phibro Animal Health (PAHC) in Q3 2025, closing a stake of 14,182 shares — an estimated $362K sold.

Corton Capital first reported a position in PAHC in Q2 2025 and held it in 1 quarter. The position peaked at $362K in Q2 2025. 218 funds tracked by Wall St. Rank hold PAHC as of Q3 2025.

Corton Capital reported no remaining Phibro Animal Health position as of Q3 2025 after selling out during the quarter.
Corton Capital sold 14,182 Phibro Animal Health shares in Q3 2025, an estimated $362K.
Corton Capital first reported a position in Phibro Animal Health in Q2 2025 and held it in 1 quarter.
Corton Capital's Phibro Animal Health position peaked at $362K in Q2 2025.
218 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2025.

Based on Corton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.